D130V substitution insensitive kinesin spindle protein inhibitors (Cytokinetics/GSK)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameD130V substitution insensitive kinesin spindle protein inhibitors (Cytokinetics/GSK)
Drug Alias NameD130V substitution insensitive KSP inhibitors (Cytokinetics/GSK)GSK-246053AGSK-246053
ClassificationSmall molecules
Mechanisms of ActionKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCytokinetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A